Yaya Scientific Awarded $100K SBIR/STTR Matching Grant from Launch Tennessee

Yaya Scientific is proud to announce that we have been selected as one of Launch Tennessee’s 2021 SBIR/STTR Matching Fund recipients, receiving a $100,000 award to accelerate the development and commercialization of our innovative technologies in the life sciences sector.

The SBIR/STTR Matching Fund is a strategic initiative by Launch Tennessee (LaunchTN) designed to advance technology-driven startups and expand high-wage job creation across the state. Now in its fourth year, the program has fueled the growth of dozens of high-tech companies, generating over $146 million in economic impact and supporting more than 500 direct jobs statewide.

“We are confident these companies are building technologies capable of changing the world, and we are excited to support them in their innovation efforts here at home to ensure we have a brighter and more competitive Tennessee tomorrow,” said Charles Layne, Innovation Manager at LaunchTN.

This year’s recipients represent a wide range of industries — from biotechnology and advanced manufacturing to cleantech and mobility — and include a strong showing of companies with diverse leadership teams. Yaya Scientific is honored to be part of this exceptional group of innovators helping to push Tennessee forward as a national hub for science and technology.

Our team will leverage this matching grant to build upon our ongoing federally funded research, strengthen our R&D capabilities, and continue transforming our scientific discoveries into impactful solutions that improve lives and drive economic growth in Tennessee.

For more information about Launch Tennessee’s SBIR/STTR program and the 2021 Matching Fund recipients, check out this article from the Upper Cumberland Business Journal:
https://www.ucbjournal.com/launch-tennessee-awards-7-million-in-matching-funds-to-over-40-tn-businesses/

Newsletter

Get the latest updates

Be a part of cutting-edge research and help us refine our technologies for broader medical impact.